Propranolol

Source: Wikipedia, the free encyclopedia.

Propranolol
Clinical data
Pronunciation/prˈprænəˌlɑːl/
Trade namesInderal, others
AHFS/Drugs.comMonograph
License data
Pregnancy
category
  • AU: C
Routes of
administration
Oral, rectal, intravenous
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability26%
Protein binding90%
MetabolismLiver (extensive) CYP1A2, CYP2D6; minor: CYP2C19, CYP3A4
MetabolitesN-desisopropylpropranolol, 4'-hydroxypropanolol
Elimination half-life4–5 hours
ExcretionKidney (<1%)
Identifiers
  • (RS)-1-(1-methylethylamino)-3-(1-naphthyloxy)propan-2-ol
JSmol)
ChiralityRacemic mixture
Melting point96 °C (205 °F)
  • OC(COC1=C2C=CC=CC2=CC=C1)CNC(C)C
  • InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3 checkY
  • Key:AQHHHDLHHXJYJD-UHFFFAOYSA-N checkY
  (verify)

Propranolol, sold under the brand name Inderal among others, is a medication of the

intravenous injection (injection into a vein).[2] The formulation that is taken orally (by mouth) comes in short-acting and long-acting versions.[2] Propranolol appears in the blood after 30 minutes and has a maximum effect between 60 and 90 minutes when taken orally.[2][5]

Common

Propranolol was patented in 1962 and approved for medical use in 1964.

generic medication.[2] In 2021, it was the 91st most commonly prescribed medication in the United States, with more than 7 million prescriptions.[10][11]

Medical uses

extended-release
propranolol
A mixture of 20 mg and 10 mg propranolol tablets
Propranolol blister pack

Propranolol is used for treating various conditions, including:

Cardiovascular

While once a first-line treatment for

type 2 diabetes.[12]

Propranolol is not recommended for the treatment of high blood pressure by the Eighth Joint National Committee (JNC 8) because a higher rate of the primary composite outcome of cardiovascular death, myocardial infarction, or stroke compared to an angiotensin receptor blocker was noted in one study.[13]

Psychiatric

Propranolol is occasionally used to treat

performance anxiety,[3] although evidence to support its use in any anxiety disorders is poor.[14] Its efficacy in managing panic disorder appears similar to benzodiazepines, while carrying lower risks for addiction or abuse.[14] Although beta-blockers such as propranolol have been suggested to be beneficial in managing physical symptoms of anxiety, its efficacy in treating generalized anxiety disorder and panic disorder remain unestablished.[15] Some experimentation has been conducted in other psychiatric areas:[16]

PTSD and phobias

Propranolol is being investigated as a potential treatment for PTSD.

social phobia.[14] It has also been found to be helpful for some individuals with Misophonia.[25]

Ethical and legal questions have been raised surrounding the use of propranolol-based medications for use as a "memory damper", including: altering memory-recalled evidence during an investigation, modifying behavioral response to past (albeit traumatic) experiences, the regulation of these drugs, and others.[26] However, Hall and Carter have argued that many such objections are "based on wildly exaggerated and unrealistic scenarios that ignore the limited action of propranolol in affecting memory, underplay the debilitating impact that PTSD has on those who suffer from it, and fail to acknowledge the extent to which drugs like alcohol are already used for this purpose".[27]

Other uses

Propranolol may be used to treat severe infantile

hemangiomas (IHs). This treatment shows promise as being superior to corticosteroids when treating IHs. Extensive clinical case evidence and a small controlled trial support its efficacy.[33]

Contraindications

Propranolol may be contraindicated in people with:[34]

Adverse effects

Propranolol should be used with caution in people with:[34]

Pregnancy and lactation

Propranolol, like other beta blockers, is classified as

premature birth. The newborn may experience additional adverse effects such as low blood sugar and a slower than normal heart rate.[35]

Most β-blocking agents appear in the milk of lactating women. However, propranolol is highly bound to proteins in the bloodstream and is distributed into breast milk at very low levels.[36] These low levels are not expected to pose any risk to the breastfeeding infant, and the American Academy of Pediatrics considers propranolol therapy "generally compatible with breastfeeding".[35][36][37][38]

Overdose

In overdose propranolol is associated with

ventricular arrhythmias, or cardiogenic shock which may ultimately culminate in bradycardic PEA.[40]

Interactions

Since beta blockers are known to relax the cardiac muscle and to constrict the smooth muscle, beta-adrenergic antagonists, including propranolol, have an additive effect with other drugs which decrease blood pressure, or which decrease cardiac contractility or conductivity. Clinically significant interactions particularly occur with:[34]

Pharmacology

Pharmacodynamics

Propranolol[42]
Site Ki (nM) Species Ref
5-HT1A 55–272 Human [43][44]
5-HT1B 56–85 Rat [45][46]
5-HT1D 4,070 Pig [47]
5-HT2A 4,280 Human [48]
5-HT2B 457–513 (+)
166–316 ()
Human [49]
5-HT2C 61,700 (+)
5,010 ()
736–2,457
Human
Human
Rodent
[49]
[49]
[50][44]
5-HT3 >10,000 Human [51]
α1 ND ND ND
α2 1,297–2,789 Rat [52]
β1 0.02–2.69 Human [53][54]
β2 0.01–0.61 Human [53][54]
β3 450 Mouse [55]
D1
>10,000 Human [44]
D2
>10,000 Human [44]
H1
>10,000 Human [56]
SERTTooltip Serotonin transporter 3,700 Rat [57]
NETTooltip Norepinephrine transporter 5,000 (
IC50
Tooltip Half-maximal inhibitory concentration)
Rat [58]
DATTooltip Dopamine transporter 29,000 (IC50) Rat [58]
VDCC
Tooltip Voltage-dependent calcium channel
>10,000 Rat [59]
Values are Ki (nM), unless otherwise noted. The smaller the value, the more strongly the drug binds to the site.

Propranolol is classified as a competitive non-cardioselective sympatholytic

overdose).[61] Propranolol is able to cross the blood–brain barrier and exert effects in the central nervous system in addition to its peripheral activity.[14]

In addition to blockade of

5-HT1A, 5-HT1B, and 5-HT2B receptors.[63][64][49] The latter may be involved in the effectiveness of propranolol in the treatment of migraine at high doses.[49]

Both enantiomers of propranolol have a local anesthetic (topical) effect, which is normally mediated by blockade of voltage-gated sodium channels. Studies have demonstrated propranolol's ability to block cardiac, neuronal, and skeletal voltage-gated sodium channels, accounting for its known membrane stabilizing effect and antiarrhythmic and other central nervous system effects.[65][66][67]

Mechanism of action

Propranolol is a non-selective beta receptor antagonist.[60] This means that it does not have preference to β1 or β2 receptors. It competes with sympathomimetic neurotransmitters for binding to receptors, which inhibits sympathetic stimulation of the heart. Blockage of neurotransmitter binding to β1 receptors on cardiac myocytes inhibits activation of adenylate cyclase, which in turn inhibits cAMP synthesis leading to reduced PKA (Protein Kinase A) activation. This results in less calcium influx to cardiac myocytes through voltage gated L-type calcium channels meaning there is a decreased sympathetic effect on cardiac cells, resulting in antihypertensive effects including reduced heart rate and lower arterial blood pressure.[68] Blockage of neurotransmitter binding to β2 receptors on smooth muscle cells will increase contraction, which will increase hypertension.

Pharmacokinetics

Propranolol is rapidly and completely absorbed, with peak plasma levels achieved about 1–3 hours after ingestion. More than 90% of the drug is found bound to plasma protein in the blood.

Hepatic impairment therefore increases its bioavailability. The main metabolite 4-hydroxypropranolol, with a longer half-life (5.2–7.5 hours) than the parent compound (3–4 hours), is also pharmacologically active. Most of the metabolites are excreted in the urine.[68]

Propranolol is a highly

lipophilic drug achieving high concentrations in the brain. The duration of action of a single oral dose is longer than the half-life and may be up to 12 hours, if the single dose is high enough (e.g., 80 mg).[70] Effective plasma concentrations are between 10 and 100 mg/L.[citation needed] Toxic levels are associated with plasma concentrations above 2000 mg/L.[citation needed
]

History

carcinogenicity
found with pronethalol in animal models.

Newer, more cardio-selective beta blockers (such as bisoprolol, nebivolol, carvedilol, or metoprolol) are now used preferentially in the treatment of hypertension.[72]

Society and culture

In a 1987 study by the International Conference of Symphony and Opera Musicians, it was reported that 27% of interviewed members said they used beta blockers such as propranolol for musical performances.[73] For about 10–16% of performers, their degree of stage fright is considered pathological.[73][74] Propranolol is used by musicians, actors, and public speakers for its ability to treat anxiety symptoms activated by the sympathetic nervous system.[75] It has also been used as a performance-enhancing drug in sports where high accuracy is required, including archery, shooting, golf,[76] and snooker.[76] In the 2008 Summer Olympics, 50-metre pistol silver medalist and 10-metre air pistol bronze medalist Kim Jong-su tested positive for propranolol and was stripped of his medals.[77]

Brand names

Propranolol was first marketed under the brand name Inderal, manufactured by ICI Pharmaceuticals (now AstraZeneca), in 1965. "Inderal" is a quasi-anagram of "Alderlin", the trade name of pronethalol (which propranolol replaced); both names are an homage to Alderley Park, the ICI headquarters where the drugs were first developed.[78]

Propranolol is also marketed under brand names Avlocardyl, Deralin, Dociton, Inderalici, InnoPran XL, Indoblok,[79] Sumial, Anaprilin, and Bedranol SR (Sandoz). In India it is marketed under brand names such as Ciplar and Ciplar LA by Cipla. Hemangeol, a 4.28 mg/mL solution of propranolol, is indicated for the treatment of proliferating infantile hemangioma.[80]

References

  1. FDA
    . Retrieved 22 October 2023.
  2. ^ a b c d e f g h i j k "Propranolol hydrochloride". Monograph. The American Society of Health-System Pharmacists. Archived from the original on 1 January 2015. Retrieved 1 January 2015.
  3. ^
    PMID 17092192
    .
  4. .
  5. from the original on 24 March 2017.
  6. ^ "Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. Archived from the original on 8 April 2014. Retrieved 22 April 2014.
  7. from the original on 14 February 2017.
  8. .
  9. . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  10. ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
  11. ^ "Propranolol - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.
  12. National Institute for Health and Clinical Excellence. Archived from the original
    on 24 September 2006. Retrieved 11 October 2009.
  13. .
  14. ^ .
  15. .
  16. .
  17. .
  18. .
  19. .
  20. ^ "Doctors test a drug to ease traumatic memories - Mental Health - NBC News". NBC News. Retrieved 30 June 2007.
  21. PMID 17588604
    .
  22. .
  23. ^ "DocFilm – DW". dw.com. Retrieved 2 August 2023.
  24. S2CID 3064619
    .
  25. .
  26. ^ Kolber AJ (2006). "Therapeutic Forgetting: The Legal and Ethical Implications of Memory Dampening". Vanderbilt Law Review, San Diego Legal Studies Paper No. 07-37. 59: 1561.
  27. S2CID 27063524
    .
  28. .
  29. .
  30. from the original on 24 March 2017.
  31. ^ Chan C, Goadsby PJ (26 September 1996). Silberstein SD (ed.). "Primary exercise headache". MedLink.
  32. S2CID 248375711
    .
  33. .
  34. ^ a b c Rossi S, ed. (2006). Australian Medicines Handbook. Adelaide: Australian Medicines Handbook.
  35. ^ .
  36. ^
    National Library of Medicine
    Toxicology Data Network. Retrieved 25 February 2013.
  37. .
  38. .
  39. .
  40. .
  41. .
  42. ^ Roth BL, Driscol J. "PDSP Ki Database". Psychoactive Drug Screening Program (PDSP). University of North Carolina at Chapel Hill and the United States National Institute of Mental Health. Retrieved 14 August 2017.
  43. PMID 2078271
    .
  44. ^ .
  45. .
  46. .
  47. .
  48. .
  49. ^ .
  50. .
  51. .
  52. .
  53. ^ .
  54. ^ .
  55. .
  56. .
  57. .
  58. ^ .
  59. .
  60. ^ .
  61. .
  62. ^ .
  63. .
  64. .
  65. .
  66. .
  67. S2CID 631197. Archived from the original
    (PDF) on 20 February 2019.
  68. ^ a b c "Propranolol". www.drugbank.ca. Retrieved 31 January 2019.
  69. .
  70. ^ "Propranolol". pubchem.ncbi.nlm.nih.gov. Retrieved 31 January 2019.
  71. PMID 14132613
    .
  72. ^ .
  73. ^ a b Fishbein M, Middlestadt SE, Ottati V, Straus S, Ellis A (1988). "Medical problems among ICSOM musicians: overview of a national survey". Med Probl Perform Artist. 3: 1–8.
  74. .
  75. .
  76. ^ a b Tim Glover. "Golf: O'Grady says players use beta-blockers: Drugs 'helped win majors'". The Independent. Archived from the original on 25 September 2015. Retrieved 28 March 2017.
  77. ^ Scott M (15 August 2008). "Olympics: North Korea's Kim Jong-su loses medals after positive drugs test". The Guardian. Guardian News and Media Limited. Retrieved 7 March 2018.
  78. PMID 16502872
    .
  79. ^ "Indoblok Tablet - Product - TabletWise.com". www.tabletwise.com. Retrieved 15 October 2022.
  80. ^ "Hemangeol - Food and Drug Administration" (PDF). 1 March 2014. Archived (PDF) from the original on 2 April 2015. Retrieved 23 March 2015.

Further reading